Sabby Management’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Sabby Management’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-141,000	Closed	-$49K	–	362
2016 Q3	$49K	Buy	141,000 +27,470	+24%	+$9.55K	﹤0.01%	301
2016 Q2	$53K	Buy	+113,530	New	+$53K	﹤0.01%	272
2015 Q2	–	Sell	-3,436,456	Closed	-$4.78M	–	400
2015 Q1	$4.78M	Buy	3,436,456 +3,295,512	+2,338%	+$4.58M	0.2%	81
2014 Q4	$213	Sell	140,944 -141,760	-50%	-$214	0.01%	212
2014 Q3	$582	Buy	282,704 +17,354	+7%	+$36	0.02%	174
2014 Q2	$812K	Sell	265,350 -442,739	-63%	-$1.35M	0.03%	165
2014 Q1	$1.77M	Buy	+708,089	New	+$1.77M	0.1%	112

Sabby Management's RXII Position: Q4 2016 in Review

Sabby Management sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 141,000 shares — an estimated $49K sold.

Sabby Management first reported a position in RXII in Q1 2014 and held it in 7 quarters. The position peaked at $4.78M in Q1 2015. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

Sabby Management reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
Sabby Management sold 141,000 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $49K.
Sabby Management first reported a position in GALENA BIOPHARMA INC COM in Q1 2014 and held it in 7 quarters.
Sabby Management's GALENA BIOPHARMA INC COM position peaked at $4.78M in Q1 2015.
0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Sabby Management's 13F filing for Q4 2016, filed 14 Feb 2017.